Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease
May 01, 2024 06:55 ET
|
Janssen Cilag International NV
Media contact:Sophie DaneauSdaneau@its.jnj.com+33 6 3178 8798Investor contact:Raychel Kruperinvestor-relations@its.jnj.com For European and UK medical and trade media only For immediate...
SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical to Johnson & Johnson
April 10, 2024 09:25 ET
|
Wohl & Fruchter LLP
We are investigating the fairness of the price of $335.00 per share in cash for which Shockwave Medical has agreed to be sold to Johnson & Johnson.
CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists
March 15, 2024 12:00 ET
|
CURE Media Group
CRANBURY, N.J., March 15, 2024 (GLOBE NEWSWIRE) -- CURE® Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients,...
PARP Inhibitor Market to Surpass USD 67.0 Billion by 2034, with 18.30% CAGR and Redefining Cancer Treatment Landscape - By PMI
February 27, 2024 14:30 ET
|
PMI
Covina, Feb. 27, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the PARP Inhibitor Market size was valued at about USD 12.5 Billion in 2024 and expected to grow at CAGR of 18.30%...
Short Bowel Syndrome Market: “Improved Digestive Health with market Size & Share to Exceed USD 3060.8 Million by 2034, at CAGR of 13.70% – By PMI
February 15, 2024 18:02 ET
|
PMI
Covina, Feb. 15, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Short Bowel Syndrome Market size was valued at about USD 850.5 Million in 2024 and expected to grow at CAGR of...
Biopharmaceutical and Biomedicine Market Size & Share to Exceed USD 1803.2 Billion by 2034, at CAGR of 12.20%. “Harnessing the Power of Genomics for Precision Medicine"– By PMI
February 12, 2024 19:30 ET
|
PMI
Covina, Feb. 12, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Biopharmaceutical and Biomedicine Market size was valued at about USD 570.0 Billion in 2024 and expected to...
Light Therapy Market Size & Share to Exceed USD 1275.0 Million by 2034, at CAGR of 6.1%. "Radiant Revolution: Illuminating the Future of Light Therapy Markets" – PMI Leads the Way
February 01, 2024 18:00 ET
|
PMI
Covina, Feb. 01, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Light Therapy Market size was valued at about USD 744.7 Million in 2024 and expected to grow at CAGR of 6.1% to...
AMAM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Ambrx Biopharma to Johnson & Johnson
January 08, 2024 09:03 ET
|
Wohl & Fruchter LLP
We are investigating the fairness of the sale of Ambrx Biopharma to Johnson & Johnson.
Axial Spondyloarthritis Market Awareness Campaigns Promote Early Diagnosis and Improved Outcomes – By PMI
October 17, 2023 13:30 ET
|
PMI
Covina, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Axial Spondyloarthritis affects joints in axial skeleton such as chest, pelvis and spine. Skin and nail changes of Psoriasis, longstanding low back pain,...
Tubeless Insulin Pump Market is estimated to be US$ 8.85 billion by 2032; Growing Prevalence of Diabetes to Fuel Market Growth – By PMI
October 04, 2023 11:00 ET
|
PMI
Covina, Oct. 04, 2023 (GLOBE NEWSWIRE) -- According to prophecy market insights “Tubeless Insulin Pump Market accounted for US$ 1.31 billion in 2022 and is estimated to be US$ 8.85...